Sell Nuvectra Corporation (NVTR) for a profit of 109%
A 109% profit in one month for investing in the speculative stock Nuvectra Corporation (NVTR) is more than enough for me, so I’ll sell it (at an average price of $9.4) and say thanks to…
A 109% profit in one month for investing in the speculative stock Nuvectra Corporation (NVTR) is more than enough for me, so I’ll sell it (at an average price of $9.4) and say thanks to…
2016 was a great year for spin-off stocks in general, and spin-off shares I purchased in particular – my spin-off portfolio produced 37.9%, almost 4 times the return of the US market, which I measure…
I bought Aptevo Therapeutics (APVO) to the spin-off portfolio at $2.40. Note: This is a biotechnology company with high risk profile. * * * Six months ago, I bought shares of Nuvectra Corporation (NVTR) –…
Nuvectra Corporation (NVTR) was recently separated from Greatbatch (GB). Nuvectra is a neuromodulation medical device company, develops and commercializes its neurostimulation technology platform for the treatment of various disorders in neuroscience and clinical markets in…